Table 5.
Description of Characteristics at baseline of those who declined, stable, or improved in global health status/QoL between baseline and 12 months
| Characteristics at baseline | Decline, N = 18 (%) | No change, N = 34 (%) | Improvement, N = 26 (%) |
| Median age at baseline (interquartile range) | 73.2 (68.1, 76.2) | 73.3 (69.1, 77.6) | 74.5 (69.1, 78.9) |
| Sex % women | 16 (88.9) | 26 (76.5) | 16 (61.5) |
| Living alone | 8 (44.4) | 11 (32.4) | 12 (46.2) |
| Social support available | 11 (61.1) | 27 (79.4) | 18 (71.8) |
| Lung cancer diagnosis versus other | 2 (11.1) | 6 (17.6) | 7 (26.9) |
| Advanced stage of disease (stage 3–4) | 6 (33.3) | 6 (17.5) | 14 (58.3)* |
| Extensive treatment received during first 6 months after diagnosis | 8 (44.4) | 9 (26.5) | 13 (50.0) |
| Median number of comorbid conditions (interquartile range) | 1.5 (0, 3) | 2.0 (1, 3) | 1.5 (0, 3) |
| ECOG PS ≥ 1 | 2 (11.1) | 8 (23.5) | 10 (38.5) |
| Presence of functional limitations | 6 (33.3) | 9 (26.5) | 7 (26.9) |
| Presence of IADL disability | 3 (16.7) | 8 (23.5) | 11 (42.5) |
| Presence of ADL disability | 2 (11.1) | 1 (2.9) | 3 (11.5) |
| Presence of mood disturbance | 1 (5.6) | 8 (24.2) | 8 (30.8) |
ADL, activities of daily living; ECOG PS, Eastern Cooperative Oncology Group performance status; IADL, instrumental activities of daily living; QoL, quality of life.
*
P < 0.05.